Ammonia metabolism and hepatic encephalopathy

被引:24
作者
Katayama, K [1 ]
机构
[1] Osaka Koseinenkin Hosp, Dept Internal Med, Fukushima Ku, Osaka 5530003, Japan
关键词
astrocyte; BCAA; GABA-BZ; glutamine; zinc;
D O I
10.1016/j.hepres.2004.08.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatic encephalopathy is a complex neuropsychiatric syndrome, which derives from liver failure associated with severe liver damage such as fulminant hepatitis and liver cirrhosis, and vascular abnormalities associated with liver cirrhosis. Although the cause is explained by a multifactorial theory, the accumulation of ammonia has traditionally been considered to have an important role in the pathogenesis of hepatic encephalopathy. In addition, a number of other possible mechanisms have recently proposed, including production of false neurotransmitter, activation of central gamma-aminobutyric acid-benzodiazepine receptors by ligands of endogenous origin, altered cerebral metabolism. These pathogenetic mechanisms are not necessarily exclusive. The principle of treatment is to remove or correct aggravating factors and inhibit the transfer of toxic substances such as ammonia into the bloodstream by minimizing the interaction of intestinal bacteria and nitrogen substances. Most treatments of proved value are based on the ammonia hypothesis. Ammonia metabolism is regulated by numerous factors, among which zinc has long been indicated to be involved, and its clinical application has drawn attention recently. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:S71 / S78
页数:8
相关论文
共 51 条
[1]   Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: An Italian multicenter double-blind, placebo-controlled, cross-over study [J].
Barbaro, G ;
Di Lorenzo, G ;
Soldini, M ;
Giancaspro, G ;
Bellomo, G ;
Belloni, G ;
Grisorio, B ;
Annese, M ;
Bacca, D ;
Francavilla, R ;
Barbarini, G .
HEPATOLOGY, 1998, 28 (02) :374-378
[2]  
BASILE AS, 1994, HEPATOLOGY, V19, P112, DOI 10.1016/0270-9139(94)90061-2
[3]   VEGETABLE VERSUS ANIMAL PROTEIN-DIET IN CIRRHOTIC-PATIENTS WITH CHRONIC ENCEPHALOPATHY - A RANDOMIZED CROSS-OVER COMPARISON [J].
BIANCHI, GP ;
MARCHESINI, G ;
FABBRI, A ;
RONDELLI, A ;
BUGIANESI, E ;
ZOLI, M ;
PISI, E .
JOURNAL OF INTERNAL MEDICINE, 1993, 233 (05) :385-392
[4]  
BODE JC, 1985, HEPATO-GASTROENTEROL, V32, P259
[5]   HEPATIC ZINC CONTENT IN PATIENTS WITH VARIOUS STAGES OF ALCOHOLIC LIVER-DISEASE AND IN PATIENTS WITH CHRONIC ACTIVE AND CHRONIC PERSISTENT HEPATITIS [J].
BODE, JC ;
HANISCH, P ;
HENNING, H ;
KOENIG, W ;
RICHTER, FW ;
BODE, C .
HEPATOLOGY, 1988, 8 (06) :1605-1609
[6]   The astrocytic ("peripheral-type") benzodiazepine receptor: role in the pathogenesis of portal-systemic encephalopathy [J].
Butterworth, RF .
NEUROCHEMISTRY INTERNATIONAL, 2000, 36 (4-5) :411-416
[7]   Effects of ammonia on glutamate transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes [J].
Chan, H ;
Hazell, AS ;
Desjardins, P ;
Butterworth, RF .
NEUROCHEMISTRY INTERNATIONAL, 2000, 37 (2-3) :243-248
[8]  
CONN HO, 1977, GASTROENTEROLOGY, V72, P573
[9]   EXTRACELLULAR BRAIN GLUTAMATE DURING ACUTE LIVER-FAILURE AND DURING ACUTE HYPERAMMONEMIA SIMULATING ACUTE LIVER-FAILURE - AN EXPERIMENTAL-STUDY BASED ON IN-VIVO BRAIN DIALYSIS [J].
DEKNEGT, RJ ;
SCHALM, SW ;
VANDERRIJT, CCD ;
FEKKES, D ;
DALM, E ;
HEKKINGWEYMA, I .
JOURNAL OF HEPATOLOGY, 1994, 20 (01) :19-26
[10]   FALSE NEUROTRANSMITTERS AND HEPATIC FAILURE [J].
FISCHER, JE ;
BALDESSARINI, RJ .
LANCET, 1971, 2 (7715) :75-+